ArticleLeukemia2018

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.

Stephen E Kurtz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.